芍药苷抗肿瘤作用机制的研究进展

doi:10.3969/j.issn.1004-616x.2024.02.015

摘要/Abstract

摘要： 芍药苷是中药赤芍、白芍的主要成分，可用于治疗肿瘤、糖尿病、心脑血管病等疾病。恶性肿瘤是全球重大的健康问题，严重威胁人类健康，并且发病率和死亡率不断上升。芍药的抗肿瘤作用得到了广泛认可，但芍药苷尚未以单体形式应用于临床，其作用机制包括促进凋亡、抗炎、调节线粒体功能、调节自噬、抑制癌细胞增殖及调节免疫等。芍药苷可通过多种方式发挥抗癌作用，在抗肿瘤治疗领域前景广阔。本文对芍药苷抗肿瘤作用机制进行综述，以期为肿瘤的临床治疗提供理论依据。

关键词: 芍药苷, 凋亡, 炎症, 自噬, 癌症

中图分类号:

R285

张璨, 林鹏, 杨玉, 杨光远, 刘明远. 芍药苷抗肿瘤作用机制的研究进展[J]. 癌变·畸变·突变, 2024, 36(2): 164-167.

参考文献

[1] ZHANG L L, WEI W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony[J]. Pharmacol Ther, 2020, 207:107452.
[2] XIN Q Q, YUAN R, SHI W L, et al. A review for the anti-inflammatory effects of paeoniflorin in inflammatory disorders[J]. Life Sci, 2019, 237:116925.
[3] LIU P, CHENG J J, MA S, et al. Paeoniflorin attenuates chronic constriction injury-induced neuropathic pain by suppressing spinal NLRP3 inflammasome activation[J]. Inflammopharmacology, 2020, 28(6):1495-1508.
[4] ZHANG Y Q, QIAO L F, XU W, et al. Paeoniflorin attenuates cerebral ischemia-induced injury by regulating Ca²⁺/CaMKII/CREB signaling pathway[J]. Molecules, 2017, 22(3):359.
[5] LIU S S, LI Y, WU C J. Paeoniflorin suppresses the apoptosis and inflammation of human coronary artery endothelial cells induced by oxidized low-density lipoprotein by regulating the Wnt/β-catenin pathway[J]. Pharm Biol, 2023, 61(1):1454-1461.
[6] XIE P Y, CUI L L, SHAN Y, et al. Antithrombotic effect and mechanism of Radix paeoniae Rubra[J]. Biomed Res Int, 2017, 2017:9475074.
[7] LI Y C, QIAO J Y, WANG B Y, et al. Paeoniflorin ameliorates fructose-induced insulin resistance and hepatic steatosis by activating LKB1/AMPK and AKT pathways[J]. Nutrients, 2019, 10(8):1024.
[8] CHEN H W, DONG Y, HE X H, et al. Paeoniflorin improves cardiac function and decreases adverse postinfarction left ventricular remodeling in a rat model of acute myocardial infarction[J]. Drug Des Devel Ther, 2018, 12:823-836.
[9] JI Y, DOU Y N, ZHAO Q W, et al. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway[J]. Acta Pharmacol Sin, 2016, 37(6):794-804.
[10] WANG X Z, XIA L, ZHANG X Y, et al. The multifaceted mechanisms of Paeoniflorin in the treatment of tumors:state-of-the-Art[J]. Biomedecine Pharmacother, 2022, 149:112800.
[11] BLEICKEN S, WAGNER C, GARCÍA-SÁEZ A J. Mechanistic differences in the membrane activity of Bax and Bcl-xL correlate with their opposing roles in apoptosis[J]. Biophys J, 2013, 104(2):421-431.
[12] 高天勤,李欣,董圣军,等.芍药苷对人上皮性卵巢癌HO8910细胞增殖、凋亡及迁移的影响及其机制研究[J].药学研究, 2019, 38(4):198-200, 204.
[13] BAI C Y. Paeoniflorin induces HepG2 cell apoptosis by regulating Caspase3 activation and nuclear factor kappa B signaling pathway[J]. World Chin J Dig, 2015, 23(22):3582.
[14] 黄巍,孙诚谊,喻超,等.芍药苷对人胰腺癌Panc-1细胞系增殖和凋亡的影响[J].贵州医科大学学报, 2018, 43(8):874-878.
[15] LI J F, ZHENG X R, ZHANG H Y, et al. Effects of sensitized sorafenib with a paeoniflorin and geniposide mixture on liver cancer via the NF-κB-HIF-2α-SerpinB3 pathway[J]. Evid Based Complement Alternat Med, 2022, 2022:1911311.
[16] TU J J, GUO Y W, HONG W M, et al. The regulatory effects of paeoniflorin and its derivative paeoniflorin-6'-O-benzene sulfonate CP-25 on inflammation and immune diseases[J]. Front Pharmacol, 2019, 10:57.
[17] 晏雪生,李瀚旻,彭亚琴,等.芍药苷对人肝癌细胞HepG-2凋亡及其调控基因的影响[J].中华中医药学刊, 2007, 25(7):1346-1347.
[18] LI Y J, GONG L L, QI R L, et al. Paeoniflorin suppresses pancreatic cancer cell growth by upregulating HTRA3 expression[J]. Drug Des Devel Ther, 2017, 11:2481-2491.
[19] ZHOU X, LEI Q Y. Regulation of TAZ in cancer[J]. Protein Cell, 2016, 7(8):548-561.
[20] NIU K, LIU Y L, ZHOU Z J, et al. Antitumor effects of paeoniflorin on hippo signaling pathway in gastric cancer cells[J]. J Oncol, 2021, 2021:4724938.
[21] LIU H, ZANG L L, ZHAO J, et al. Paeoniflorin inhibits cell viability and invasion of liver cancer cells via inhibition of Skp2[J]. Oncol Lett, 2020, 19(4):3165-3172.
[22] 李林海.线粒体DNA突变与乳腺癌风险相关性研究[D].广州:南方医科大学, 2015.
[23] XIANG Y J, ZHANG Q, WEI S J, et al. Paeoniflorin:a monoterpene glycoside from plants of Paeoniaceae family with diverse anticancer activities[J]. J Pharm Pharmacol, 2020, 72(4):483-495.
[24] CHANG W, JIANG X P, JIN S, et al. Synergistic effects of CP-25 and 5-fluorouracil on the hepatocellular carcinoma in vivo and in vitro through regulating activating mitochondrial pathway[J]. J Cancer, 2022, 13(3):1005-1018.
[25] 魏智民,孙玉发,李刚,等.癌症相关性炎症与肿瘤微环境相关研究进展[J].中国肿瘤临床, 2018, 45(21):1117-1121.
[26] CIESIELSKA A, MATYJEK M, KWIATKOWSKA K. TLR4 and CD14 trafficking and its influence on LPS-induced pro-inflammatory signaling[J]. Cell Mol Life Sci, 2021, 78(4):1233-1261.
[27] WANG Y X, ZHOU Y, LIN H, et al. Paeoniflorin inhibits the proliferation and metastasis of ulcerative colitis-associated colon cancer by targeting EGFL7[J]. J Oncol, 2022, 2022:7498771.
[28] 杨松林,邹浩,张小文. SOCS3在肝胆管肿瘤中作用的研究[J].医学研究杂志, 2019, 48(4):13-15, 19.
[29] GAO M, ZHANG D J, JIANG C H, et al. Paeoniflorin inhibits hepatocellular carcinoma growth by reducing PD-L1 expression[J]. Biomed Pharmacother, 2023, 166:115317.
[30] FERRO F, SERVAIS S, BESSON P, et al. Autophagy and mitophagy in cancer metabolic remodelling[J]. Semin Cell Dev Biol, 2020, 98:129-138.
[31] MARENINOVA O A, JIA W Z, GRETLER S R, et al. Transgenic expression of GFP-LC3 perturbs autophagy in exocrine pancreas and acute pancreatitis responses in mice[J]. Autophagy, 2020, 16(11):2084-2097.
[32] LIU Z, WANG Z T, CHEN D M, et al. Paeoniflorin inhibits EMT and angiogenesis in human glioblastoma via K63-linked C-met polyubiquitination-dependent autophagic degradation[J]. Front Oncol, 2022, 12:785345.
[33] 司晓丽,韩玉梅,王家敏,等.芍药苷对结肠癌SW480细胞增殖、侵袭、迁移的影响[J].中国组织化学与细胞化学杂志, 2019, 28(2):127-133.
[34] SUN R J, LIU J, YU M Y, et al. Paeoniflorin ameliorates BiPN by reducing IL6 levels and regulating PARKIN-mediated mitochondrial autophagy[J]. Drug Des Devel Ther, 2022, 16:2241-2259.
[35] 司晓丽.芍药苷对结肠炎相关性结直肠癌的化学预防作用及机制研究[D].兰州:兰州大学, 2022.
[36] ZHANG J X, WANG F C, WANG H L, et al. Paeoniflorin inhibits proliferation of endometrial cancer cells via activating MAPK and NF-κB signaling pathways[J]. Exp Ther Med, 2017, 14(6):5445-5451.
[37] GAO Z W, HUANG Y Y, ZHANG J Q, et al. Paeoniflorin elicits the anti-proliferative effects on glioma cell via targeting translocator protein 18KDa[J]. J Pharmacol Sci, 2021, 145(1):115-121.
[38] YANG J H, REN Y, LOU Z G, et al. Paeoniflorin inhibits the growth of bladder carcinoma via deactivation of STAT3[J]. Acta Pharm, 2018, 68(2):211-222.
[39] LU J T, ZHAO W D, HE W, et al. Hedgehog signaling pathway mediates invasion and metastasis of hepatocellular carcinoma via ERK pathway[J]. Acta Pharmacol Sin, 2012, 33(5):691-700.
[40] 陈刚领,苏雪,林芳珍,等.芍药苷对Lewis肺癌自发肺转移小鼠的抑瘤作用[J].中药药理与临床, 2013, 29(3):61-62.
[41] ZHANG J W, LI L X, WU W Z, et al. Anti-tumor effects of paeoniflorin on epithelial-to-mesenchymal transition in human colorectal cancer cells[J]. Med Sci Monit, 2018, 24:6405-6413.
[42] GAO J Y, SONG L, XIA H, et al. 6'-O-galloylpaeoniflorin regulates proliferation and metastasis of non-small cell lung cancer through AMPK/miR-299-5p/ATF2 axis[J]. Respir Res, 2020, 21(1):39.
[43] 韩旭华.白芍有效成分经皮微乳的抗炎镇痛作用及其药效物质基础[D].北京:北京中医药大学,2006.